Skip to main content
. 2021 May 14;5(7):e10507. doi: 10.1002/jbm4.10507

TABLE 1.

Characteristics of patients at the index hospitalization by fracture type (analysis population: period January 1, 2009–December 31, 2014)

Characteristic Hip Vertebra Pelvis Multiple ribs Proximal humerus Total
Patients (% of total), n (%) 215,672 (60.4) 32,231 (9.0) 38,620 (10.8) 17,450 (4.9) 52,922 (14.8) 356,895 (100)
Fracture within 3 previous years, n (%) 9286 (4.3) 838 (2.6) 1725 (19.5) 448 (2.6) 1912 (3.4) 14,209 (4.0)
Age (years)
Mean ± SD 81.8 ± 10.6 70.5 ± 12.4 79.5 ± 11.8 71.9 ± 13.3 73.8 ± 12.1 78.8 ± 12.0
≤65 years, n (%) 20,623 (9.6) 12,042 (37.4) 5,779 (15.0) 6255 (35.8) 14,309 (27.0) 59,008 (16.5)
65–80 years, n (%) 47,470 (22.0) 10,859 (33.7) 9,243 (23.9) 4973 (28.5) 18,244 (34.5) 90,789 (25.4)
>80 years, n (%) 147,579 (68.4) 9,330 (28.9) 23,598 (61.1) 6222 (35.7) 20,369 (38.5) 207,098 (58.0)
Gender, n (% women) 167,431 (77.6) 19,221(59.6) 29,767 (77.1) 7626 (43.7) 41,713 (78.8) 265,758 (74.5)
Charlson score
Mean ± SD 0.6 ± 1.0 0.4 ± 0.9 0.5 ± 1.0 0.5 ± 1.0 0.5 ± 0.9 0.6 ± 1.0
0, n (%) 130,917 (60.7) 22,730 (70.5) 24,809 (64.2) 11,183 (64.1) 35,242 (66.6) 224,881 (63.0)
1–2, n (%) 74,021 (34.3) 8609 (26.7) 12,199 (31.6) 5565 (31.9) 16,035 (30.3) 116,429 (32.6)
3–4, n (%) 7652 (3.5) 615 (1.9) 1139 (2.9) 497 (2.8) 1149 (2.2) 11,052 (3.1)
≥5, n (%) 3082 (1.4) 277 (0.9) 473 (1.2) 205 (1.2) 496 (0.9) 4533 (1.3)
Comorbidities, n (%) a
Diabetes 23,950 (11.1) 3700 (11.5) 4532 (11.7) 2411 (13.8) 7547 (14.3) 42,140 (11.8)
CLD 24,452 (11.3) 3766 (11.7) 4695 (12.2) 2699 (15.5) 6092 (11.5) 41,704 (11.7)
Dementia 29,362 (13.6) 1203 (3.7) 3105 (8.0) 874 (5.0) 3025 (5.7) 37,569 (10.5)
Stroke 7432 (3.4) 595 (1.8) 948 (2.5) 386 (2.2) 1052 (2.0) 10,413 (2.9)
CHF 9825 (4.6) 697 (2.2) 1583 (4.1) 568 (3.3) 1121 (2.1) 13,794 (3.9)
MI 3494 (1.6) 309 (1.0) 521 (1.3) 227 (1.3) 486 (0.9) 5037 (1.4)

Abbreviations: CHF, congestive heart failure; CLD, chronic lung disease; MI, myocardial infarction; SD, standard deviation.

a

Only comorbidities used to construct the Charlson comorbidity index and identified in >1% of patients overall are listed.